This strategy is more useful in those cancers including NSCLC, glioma, and breast-cancer subtypes other than TNBC, colorectal cancer, and renal-cell carcinoma, where SCUBE family proteins play a role as tumor suppressors. This evidence concerns the gene SCUBE2 and breast cancer.